Andy Richards

Member of the Advisory Panel

Dr Andy Richards CBE has an established track record in founding and scaling up innovative Biotech and Healthtech companies in the UK. He is currently Chairman of Arecor, Congenica, Abcodia, and the Babraham Research Campus and is a Director of Ieso Digital Health, Silence Therapeutics plc, Cancer Research Technology (commercial arm of CR-UK), Sensiia Ltd, and Cambridge University Hospitals NHS Foundation Trust. As well as being an advisor to Cambridge Innovation Capital, he also advises the UCL Technology Fund.

His early career spanned positions with ICI (now AstraZeneca) and PA Technology, and he was a founder and executive director of Chiroscience plc. Since 1999 he has founded, invested in and helped to scale more than 25 innovative ventures including companies such as Vectura, Arakis, Cambridge Biotechnology Ltd and Geneservice.  Andy is also a founder member of the Cambridge Angels and a trustee of the British Science Association.

Dr Richards is a graduate of the University of Cambridge with a PhD in Chemistry.